PROCEPT BioRobotics Corp
PRCT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001588978
In the last 90 days, PROCEPT BioRobotics Corp insiders filed 1 open-market purchase and 3 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in PROCEPT BioRobotics Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- +4 vs. Q1 2023
- Shares held
- 36.0M
- +3.02M (+9.2%) vs. Q1 2023
- Total value
- $1.27B
- +$333.4M (+35.6%) vs. Q1 2023
- New holders
- 26
- 59 more added
- Sold out
- 22
- 20 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 253 | $1.24B |
| Q1 2026 | 257 | $1.40B |
| Q4 2025 | 263 | $1.77B |
| Q3 2025 | 242 | $2.06B |
| Q2 2025 | 271 | $3.07B |
| Q1 2025 | 279 | $2.94B |
| Q4 2024 | 281 | $4.06B |
| Q3 2024 | 250 | $3.65B |
| Q2 2024 | 202 | $2.69B |
| Q1 2024 | 162 | $2.26B |
| Q4 2023 | 145 | $1.91B |
| Q3 2023 | 127 | $1.46B |
| Q2 2023 | 120 | $1.27B |
| Q1 2023 | 116 | $937.6M |
| Q4 2022 | 116 | $1.36B |
| Q3 2022 | 104 | $1.40B |
| Q2 2022 | 96 | $1.14B |
| Q1 2022 | 58 | $1.08B |
| Q4 2021 | 60 | $732.3M |
| Q3 2021 | 58 | $1.03B |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding PROCEPT BioRobotics Corp; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 329,364 | $11.6M | 0.00% | +90,200+37.7% | Added |
| Polar Asset Management Partners Inc. | 333,286 | $11.8M | 0.23% | +333,286 | New |
| Eagle Health Investments LP | 337,218 | $11.9M | 2.23% | +53,000+18.6% | Added |
| Johnson & Johnson | 357,939 | $12.7M | 3.93% | 00.0% | Unchanged |
| Frank, Rimerman Advisors LLC | 456,953 | $16.2M | 3.86% | 00.0% | Unchanged |
| Citadel Advisors LLC | 475,611 | $16.8M | 0.02% | −494,029−50.9% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 500,886 | $17.7M | 0.04% | +116,664+30.4% | Added |
| American Century Companies Inc | 573,761 | $20.3M | 0.02% | +573,761 | New |
| Allspring Global Investments Holdings, LLC | 620,434 | $21.9M | 0.04% | +499,727+414.0% | Added |
| Massachusetts Financial Services Co | 676,872 | $23.9M | 0.01% | +134,554+24.8% | Added |
| Loomis Sayles & Co L P | 708,704 | $25.1M | 0.04% | −6,688−0.9% | Reduced |
| Geode Capital Management, LLC | 713,191 | $25.2M | 0.00% | +119,313+20.1% | Added |
| Bellevue Group AG | 741,517 | $26.2M | 0.37% | 00.0% | Unchanged |
| State Street Corp | 1,062,730 | $37.6M | 0.00% | +265,072+33.2% | Added |
| Price T Rowe Associates Inc | 1,531,340 | $54.1M | 0.01% | +187,575+14.0% | Added |
| BlackRock Inc. | 2,580,126 | $91.2M | 0.00% | +684,194+36.1% | Added |
| T. Rowe Price Investment Management, Inc. | 3,027,667 | $107.0M | 0.07% | +302,378+11.1% | Added |
| Vanguard Group Inc | 3,689,620 | $130.4M | 0.00% | +420,850+12.9% | Added |
| CPMG Inc | 5,328,867 | $188.4M | 37.79% | 00.0% | Unchanged |
| FMR LLC | 6,683,096 | $236.2M | 0.02% | −46,777−0.7% | Reduced |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −338,950−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −107,959−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −82,747−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −76,923−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −67,252−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −63,566−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −52,746−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −52,508−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −52,024−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −33,392−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −30,702−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −23,381−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −22,192−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −18,098−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,027−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −10,725−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,520−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −7,228−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −1,836−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −435−100.0% | Sold out |